Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer
Titel:
Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer
Auteur:
Kim, Richard D. McDonough, Shannon El-Khoueiry, Anthony B. Bekaii-Saab, Tanios S. Stein, Stacey M. Sahai, Vaibhav Keogh, George P. Kim, Edward J. Baron, Ari D. Siegel, Abby B. Barzi, Afsaneh Guthrie, Katherine A. Javle, Milind Hochster, Howard